Evaluation of a drug reconciliation service in private hospital in Fortaleza-CE: quality indicators
Objective: Analyze the registered results of this drug conciliation service on hospital admission to a private hospital in Fortaleza-CE, based on quality indicators, such as the reconciliation rate and operations performed. Methods: A cross-sectional retrospective study in which anamnesis data was collected in the medication reconciliation service of a private hospital in Fortaleza-CE, and with the registration of patients, data such as name, responsible physician, age, pharmaceutical intervention carried out, highlighting its impact on the quality of service for increasing patient safety, and with these records an analysis of the indicators was made in relation to the doctors’ acceptance and the monitoring in relation to the validation of the prescribed drugs and classes, in July to December 2018. 833 patients (divided into Clinical and surgical ones) with more than 48 hours of hospitalization were included, in whom medication reconciliation was performed at the time of admission to the 7 hospitalization stations present at the hospital. Results: 119 patients were reconciled in the study and that among the patients 294 interventions were performed, of which 228 were accepted, showing high performance in terms of acceptance, efficiency and quality of service. In addition, there was a result of high acceptance in the month following the implantation, in August, with 29.4%, falling in October to 9.3%, suggesting that the service improved the prescription culture, requiring fewer interventions and promoting a increasing patient safety. The main intervention was the addition of medications, evidencing the communication to the medical team of the existence of comorbidities that were not being treated. Conclusion: The medication reconciliation in the hospital environment identified the need to add medications, as the most common intervention. In addition to the need to communicate patients’ comorbidities to the medical team, because of this intervention presenting itself as a great tool with the participation of the pharmacist in the clinical care of the patient in order to promote patient safety, increasing the quality of the prescription at the time of hospitalization.
Copyright (c) 2021 RBFHSS and the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.